The vote is in: The European Parliament has adopted the compromise pharmaceutical legislation
This week, the European Parliament voted to adopt the compromise texts of both the revised pharmaceutical directive and regulation presented by Parliament’s health committee in March 2024. MEP statements during a debate ahead of the vote highlighted alignment on provisions such as regulatory data protection and incentives for antimicrobial research. Now, the texts head to the trilogue after European Parliament elections in June.
Fill out the form to read the full article.
Required *